Rider, L. G., Aggarwal, R., Bayat, N., Erman, B., Feldman, B. M., Huber, A. M., … Ruperto, N. (2014). A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials. ARTHRITIS & RHEUMATOLOGY, 66, S578–S578.

Rider, Lisa G., Rohit Aggarwal, Nastaran Bayat, Brian Erman, Brian M. Feldman, Adam M. Huber, Rolando Cimaz, et al. “A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials.” ARTHRITIS & RHEUMATOLOGY 66 (October 1, 2014): S578–S578.

Rider LG, Aggarwal R, Bayat N, Erman B, Feldman BM, Huber AM, et al. A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials. ARTHRITIS & RHEUMATOLOGY. 2014 Oct 1;66:S578–S578.

Rider, Lisa G., et al. “A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials.” ARTHRITIS & RHEUMATOLOGY, vol. 66, WILEY-BLACKWELL, Oct. 2014, pp. S578–S578.

Rider LG, Aggarwal R, Bayat N, Erman B, Feldman BM, Huber AM, Cimaz R, Cuttica RJ, Feitosa de Oliveira SK, Lindsley CB, Pilkington CA, Punaro MG, Ravelli A, Reed AM, Rouster-Stevens KA, van Royen-Kerkhof A, Villa L, Rinaldi M, Pistorio A, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J, Ruperto N. A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials. ARTHRITIS & RHEUMATOLOGY. WILEY-BLACKWELL; 2014 Oct 1;66:S578–S578.